PROJECT 002? SIGNAL TRANSDUCTION AND CHEMICAL BIOLOGY RESEARCH PROGRAM PROJECT SUMMARY/ABSTRACT The Signal Transduction and Chemical Biology Research Program (ST) pursues fundamental cancer research to understand patient- and cancer-specific rewiring of signaling networks and the cell cycle, and how stem/progenitor cell plasticity and heterogeneity contribute to tumorigenesis. This information is used to identify new targets that could be the focus of future drug discovery efforts. Accordingly, an overarching goal of ST is to develop novel and/or test small molecule leads against important drivers of cancer initiation and progression and aid the optimization of `leads' to drugs so that ST discoveries can be translated to the clinic as new cancer interventions. The major role of ST leadership is to ensure communication between clinical investigators, population-based researchers and basic scientists to ensure that potentially translatable findings are explored. ST leadership and Vanderbilt-Ingram Cancer Center (VICC) sponsor meetings and retreats to ensure that communication of the basic science discoveries is robust. Program goals will be accomplished by: 1) performing cutting-edge research in single cell biology, stem cells and signaling networks, to identify key targets that confer selective dependencies in human cancers; 2) promoting cutting edge research in chemical biology and development of new cancer therapeutics; and 3) stimulating interactions among the Program membership to accelerate discovery, mentor junior faculty, foster collaborations with clinical programs, promote technologies such as scRNA-seq, super-resolution microscopy, mass cytometry and PROTACS, and work closely with VICC Shared Resources to develop new instrumentation for cancer discovery. There are 44 program members from 13 departments and four schools with $11M in total peer-reviewed funding and NCI making up 39% ($4.3M). Out of 372 publications, 15% are intra-programmatic and 34% are inter-programmatic. Members also have 115 collaborative publications with investigators at other NCI-designated cancer centers.

Public Health Relevance

PROJECT 002 ? SIGNAL TRANSDUCTION AND CHEMICAL BIOLOGY RESEARCH PROGRAM PROJECT NARRATIVE Per the PAR-17-095 FOA, the project narrative is not applicable for the Signal Transduction and Chemical Biology Research Program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA068485-25
Application #
10024645
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1998-09-01
Project End
2025-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
25
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Cardin, Dana B; Thota, Ramya; Goff, Laura W et al. (2018) A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer. Am J Clin Oncol 41:772-776
Bloodworth, Melissa H; Rusznak, Mark; Pfister, Connor C et al. (2018) Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology. J Allergy Clin Immunol 142:683-687.e12
Saito-Diaz, Kenyi; Benchabane, Hassina; Tiwari, Ajit et al. (2018) APC Inhibits Ligand-Independent Wnt Signaling by the Clathrin Endocytic Pathway. Dev Cell 44:566-581.e8
Dutter, Brendan F; Ender, Anna; Sulikowski, Gary A et al. (2018) Rhodol-based thallium sensors for cellular imaging of potassium channel activity. Org Biomol Chem 16:5575-5579
Hormuth 2nd, David A; Weis, Jared A; Barnes, Stephanie L et al. (2018) Biophysical Modeling of In Vivo Glioma Response After Whole-Brain Radiation Therapy in a Murine Model of Brain Cancer. Int J Radiat Oncol Biol Phys 100:1270-1279
Rojas, Juan D; Lin, Fanglue; Chiang, Yun-Chen et al. (2018) Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy. Theranostics 8:141-155
Lewis Jr, James S; Shelton, Jeremy; Kuhs, Krystle Lang et al. (2018) p16 Immunohistochemistry in Oropharyngeal Squamous Cell Carcinoma Using the E6H4 Antibody Clone: A Technical Method Study for Optimal Dilution. Head Neck Pathol 12:440-447
Vierra, Nicholas C; Dickerson, Matthew T; Jordan, Kelli L et al. (2018) TALK-1 reduces delta-cell endoplasmic reticulum and cytoplasmic calcium levels limiting somatostatin secretion. Mol Metab 9:84-97
Schlegel, Cameron; Weis, Victoria G; Knowles, Byron C et al. (2018) Apical Membrane Alterations in Non-intestinal Organs in Microvillus Inclusion Disease. Dig Dis Sci 63:356-365
Werfel, Thomas A; Wang, Shan; Jackson, Meredith A et al. (2018) Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival. Cancer Res 78:1845-1858

Showing the most recent 10 out of 2462 publications